Cargando…

Evaluating Outcomes of Mother-Infant Pairs Using Dolutegravir for Treatment of HIV During Pregnancy

BACKGROUND: Dolutegravir (DTG) is a highly efficacious and well tolerated antiretroviral (ART) for the treatment of HIV infection. Although on the preferred treatment list for people living with HIV, it is not a treatment option for pregnant women because data on efficacy, tolerability during pregna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sibliss, Kedesha, Kirby, Olivia, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Momplaisir, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631320/ http://dx.doi.org/10.1093/ofid/ofx163.1775

Ejemplares similares

Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy
por: Grayhack, Clara, et al.
Publicado: (2018)

611. Placental Pathology and Neonatal Outcomes in Pregnancies of Perinatally vs. Nonperinatally HIV-Infected Women
por: Zeineddine, Nabil, et al.
Publicado: (2018)

Assessing the Acceptability of a Community-Based Intervention to Improve the Continuum of Care of Postpartum Women Living with HIV
por: Akinde, Yetunde, et al.
Publicado: (2017)

Assessing the Acceptability of a Peer Mentor Mother Intervention to Improve Retention in Care of Postpartum Women Living with HIV
por: Akinde, Yetunde, et al.
Publicado: (2019)

2393. Factors Associated with Time to COVID-19 Vaccination among People with HIV
por: Paz, Aasith Villavicencio, et al.
Publicado: (2023)

Outcome expectancies toward adherence to antiretroviral therapy for pregnant and postpartum women with HIV
por: Momplaisir, Florence M, et al.
Publicado: (2021)

Improving postpartum retention in care for women living with HIV in the United States
por: Momplaisir, Florence M., et al.
Publicado: (2018)

Understanding Drivers of Coronavirus Disease 2019 Vaccine Hesitancy Among Blacks
por: Momplaisir, Florence, et al.
Publicado: (2021)

Streptococcus pyogenes and invasive central nervous system infection
por: Randhawa, Ekamjeet, et al.
Publicado: (2018)

Strategies to improve outcomes of youth experiencing healthcare transition from pediatric to adult HIV care in a large U.S. city
por: Momplaisir, Florence, et al.
Publicado: (2023)

Integrating ART adherence support technologies in the care of pregnant and postpartum people with HIV: a qualitative study
por: Rendell, Sara, et al.
Publicado: (2022)

First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothers
por: Francois, Kesner, et al.
Publicado: (2023)

HIV Antiretroviral Resistance and Transmission in Mother–Infant Pairs Enrolled in a Large Perinatal Study
por: Yeganeh, Nava, et al.
Publicado: (2017)

Effect of heartfulness meditation on burnout, emotional wellness, and telomere length in health care professionals
por: Thimmapuram, Jayaram, et al.
Publicado: (2017)

1512. Stakeholder Perspectives on Universal HIV Screening in Philadelphia Emergency Rooms
por: Aitcheson, Nancy, et al.
Publicado: (2023)

Predictors of Measles and Rubella Serostatus in Mother–Infant Pairs in Rural Nepal
por: Murray, Alastair, et al.
Publicado: (2017)

Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013
por: Thompson, Dana R., et al.
Publicado: (2015)

Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals
por: Momplaisir, Florence M., et al.
Publicado: (2021)

74. Maternal Dolutegravir (DTG) Use During Pregnancy and Birth Outcomes: The Antiretroviral Pregnancy Registry (APR)
por: Vannappagari, Vani, et al.
Publicado: (2021)

A Multicenter Analysis of Elvitegravir Use During Pregnancy on HIV Viral Suppression and Perinatal Outcomes
por: Badell, Martina L, et al.
Publicado: (2019)

Durability and Kinetics of Maternal Pertussis Antibodies in Infants of Mothers Immunized with Tdap During Pregnancy
por: Healy, C Mary, et al.
Publicado: (2017)

Small-for-Gestational-Age Births in Pregnant Women with HIV, due to Severity of HIV Disease, Not Antiretroviral Therapy
por: Aaron, Erika, et al.
Publicado: (2012)

549. Weight and BMI Changes in HIV-Infected Virologically Suppressed Adults after Switching to an Elvitegravir- or Dolutegravir-Containing Regimen
por: Gibson, Amanda, et al.
Publicado: (2018)

Inconsistent Wassermann Findings in Mother and Infant
Publicado: (1914)

Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use
por: Crawford, Melissa, et al.
Publicado: (2020)

The role of dolutegravir in the management of HIV infection
por: Miller, Misty M, et al.
Publicado: (2015)

1586. Impact of Dolutegravir-based Regimen on Metabolic Syndrome and its Components in Adults with HIV in Care at Hospital Roosevelt in Guatemala City
por: Farfán, Alvaro J Mazariegos, et al.
Publicado: (2023)

2541. Steady-state PK of Fixed Dose Dolutegravir+Rilpivirine in Hemodialysis
por: Gupta, Samir K, et al.
Publicado: (2023)

2738. Influenza Vaccination During Pregnancy Among Mothers of Infants with Acute Respiratory Illness, United States, 2016–2018
por: Ogokeh, Constance E, et al.
Publicado: (2019)

How to Save a Failing Fellowship: Drexel Infectious Disease Improvement in ACGME Fellow Survey Results
por: Schultz, Sara, et al.
Publicado: (2017)

2486. Clinical Outcomes of Patients Treated with Dolutegravir Functional Monotherapy or Dolutegravir plus an Active Non-cytosine Nucleoside Analog: A Retrospective Observational Cohort Study of Treatment-Experienced Patients
por: Rolle, Charlotte-Paige M, et al.
Publicado: (2019)

2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen
por: Ward, Douglas, et al.
Publicado: (2019)

1498. Geographic differences in weight change on dolutegravir: a prospective cohort study
por: Chen, Geoffrey, et al.
Publicado: (2023)

Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir
por: Vannappagari, Vani, et al.
Publicado: (2019)

Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
por: Taha, Huda, et al.
Publicado: (2015)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers, Ellen, et al.
Publicado: (2018)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
por: Chapola, John C., et al.
Publicado: (2023)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Viral Failure Among Persons Living with HIV Initiating Dolutegravir-Based vs. Other Recommended Regimens in Real-World Clinical Care Settings
por: Nance, Robin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v62jqss7asdi3nphn2tt98agnk